Skip to content

Comparision of the risk factors which will cause high BP readings and complications of high BP readings in pregnancy between normal BP pregnant lady and the high BP pregnant lady

Correlation of onset of preeclampsia in hypertensive disorders in pregnancy, admitted for delivery by FOGSI HDP-Gestosis score in a tertiary care hospital: a case control study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/11/097515
Enrollment
400
Registered
2025-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O149- Unspecified pre-eclampsia

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil Intervention4: Nil: Nil

Sponsors

Manoj TP
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Antenatal women diagnosed with hypertensive disorders in pregnancy whether presenting with blood pressure readings more than or equal to 140 by 90 mmHg at the time of admission for delivery or those already on antihypertensive medications with controlled blood pressure less than 140 by 90 mmHg will be included as cases upon admission to the labor room Antenatal women with normal Blood Pressure admitted for delivery will be taken as controls Patients who are willing to give consents will be included

Exclusion criteria

Exclusion criteria: Any women admitted for delivery in the labor room and are not willing to give consent

Design outcomes

Primary

MeasureTime frame
To assess the correlation using FOGSI[Federation of Obstetrics and Gynecological societies of India] HDP-Gestosis score for development of preeclampsia in patients with hypertensive disorders in pregnancy versus normotensive women.Timepoint: 28 weeks to 42 weeks

Secondary

MeasureTime frame
To evaluate the feto-maternal outcomes in Hypertensive diseases in pregnancy (HDP).Timepoint: 28 weeks to 42 weeks

Countries

India

Contacts

Public ContactDr Shruthi Andola

KLES Dr Prabhakar Kore Hospital and Medical Research Centre, JNMC, Belagavi

shrutiandola@gmail.com7760710689

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026